TY - JOUR
T1 - Endotoxin contamination alters macrophage-cancer cell interaction and therapeutic efficacy in pre-clinical 3D in vitro models
AU - Heinrich, Marcel Alexander
AU - Heinrich, Lena
AU - Ankone, Marc J.K.
AU - Vergauwen, Bjorn
AU - Prakash, Jai
N1 - Funding Information:
M.A.H. and J.P. conceived the study, designed experiments and co-wrote the manuscript. M.A.H. and L. H. performed the experiments. M.J.K.A. performed the mechanical analysis of the bioprinted constructs. B.V. provided support and guidance on the study. All authors reviewed the manuscript. Correspondence and requests should be addressed to J.P. The authors would like to thank Rousselot NV Gent for supplying the X-Pure gelatin and GelMA as well as Elien Gevaert, Catarina Ferreira de Silva and Praneeth Kuninty for scientific discussion. The study was funded by Rousselot NV (to J.P).
Publisher Copyright:
© 2022 The Authors
PY - 2023/1
Y1 - 2023/1
N2 - The rapid developments in biofabrication, in particular 3D bioprinting, in the recent years have facilitated the need for novel biomaterials that aim to replicate the target tissue in great detail. The presence of endotoxins in these biomaterials is often an overlooked problem. In pre-clinical 3D in vitro models, endotoxins can have significant influence on cell behavior and credibility of the model. In this study we demonstrate the effects of high levels of endotoxins in commercially-available gelatin on the macrophage-cancer cell crosstalk in a 3D bioprinted co-culture model. First, it is demonstrated that, while presenting the same mechanical and structural stimuli, high levels of endotoxin can have significant influence on the metabolic activity of macrophages and cancer cells. Furthermore, this study shows that high endotoxin contamination causes a strong inflammatory reaction in macrophages and significantly inhibits the effects of a paracrine macrophage-cancer cell co-culture. At last, it is demonstrated that the differences in endotoxin levels can drastically alter the efficacy of novel macrophage modulating immunotherapies, AS1517499 and 3-methyladenine. Altogether, this study shows that endotoxin contamination in biomaterials can significantly alter intra- and intercellular communication and thereby drug efficacy, which might lead to misinterpretation of the potency and safety of the tested compounds.
AB - The rapid developments in biofabrication, in particular 3D bioprinting, in the recent years have facilitated the need for novel biomaterials that aim to replicate the target tissue in great detail. The presence of endotoxins in these biomaterials is often an overlooked problem. In pre-clinical 3D in vitro models, endotoxins can have significant influence on cell behavior and credibility of the model. In this study we demonstrate the effects of high levels of endotoxins in commercially-available gelatin on the macrophage-cancer cell crosstalk in a 3D bioprinted co-culture model. First, it is demonstrated that, while presenting the same mechanical and structural stimuli, high levels of endotoxin can have significant influence on the metabolic activity of macrophages and cancer cells. Furthermore, this study shows that high endotoxin contamination causes a strong inflammatory reaction in macrophages and significantly inhibits the effects of a paracrine macrophage-cancer cell co-culture. At last, it is demonstrated that the differences in endotoxin levels can drastically alter the efficacy of novel macrophage modulating immunotherapies, AS1517499 and 3-methyladenine. Altogether, this study shows that endotoxin contamination in biomaterials can significantly alter intra- and intercellular communication and thereby drug efficacy, which might lead to misinterpretation of the potency and safety of the tested compounds.
KW - 3D bioprinting
KW - Gelatin methacryloyl
KW - Immunotherapy
KW - Lipopolysaccharide
KW - Tumor-associated macrophages
KW - UT-Hybrid-D
UR - http://www.scopus.com/inward/record.url?scp=85143504309&partnerID=8YFLogxK
U2 - 10.1016/j.bioadv.2022.213220
DO - 10.1016/j.bioadv.2022.213220
M3 - Article
AN - SCOPUS:85143504309
SN - 2772-9508
VL - 144
JO - Biomaterials Advances
JF - Biomaterials Advances
M1 - 213220
ER -